Gusdon Aaron M, Fu Chenlian, Putluri Vasanta, Paz Atzhiry S, Chen Hua, Ren Xuefang, Hassan Mohammed Khurshidul, Dash Pramod, Coarfa Cristian, Putluri Nagireddy, Choi Huimahn A, Savarraj Jude P J
Division of Neurocritical Care, Department of Neurosurgery, McGovern School of Medicine, University of Texas Health Science Center, Houston, TX, USA.
Department of Neurobiology and Anatomy, McGovern School of Medicine, University of Texas Health Science Center, Houston, TX, USA.
Neurocrit Care. 2022 Dec;37(3):724-734. doi: 10.1007/s12028-022-01546-8. Epub 2022 Jul 8.
Aneurysmal subarachnoid hemorrhage (aSAH) leads to a robust systemic inflammatory response. We hypothesized that an early systemic glycolytic shift occurs after aSAH, resulting in a unique metabolic signature and affecting systemic inflammation.
Control patients and patients with aSAH were analyzed. Samples from patients with aSAH were collected within 24 h of aneurysmal rupture. Mass spectrometry-based metabolomics was performed to assess relative abundance of 16 metabolites involved in the tricarboxylic acid cycle, glycolysis, and pentose phosphate pathway. Principal component analysis was used to segregate control patients from patients with aSAH. Dendrograms were developed to depict correlations between metabolites and cytokines. Analytic models predicting functional outcomes were developed, and receiver operating curves were compared.
A total of 122 patients with aSAH and 38 control patients were included. Patients with aSAH had higher levels of glycolytic metabolites (3-phosphoglycerate/2-phosphoglycerate, lactate) but lower levels of oxidative metabolites (succinate, malate, fumarate, and oxalate). Patients with higher clinical severity (Hunt-Hess Scale score ≥ 4) had higher levels of glyceraldehyde 3-phosphate and citrate but lower levels of α-ketoglutarate and glutamine. Principal component analysis readily segregated control patients from patients with aSAH. Correlation analysis revealed distinct clusters in control patients that were not observed in patients with aSAH. Higher levels of fumarate were associated with good functional outcomes at discharge (odds ratio [OR] 1.76, 95% confidence interval [CI] 1.15-2.82) in multivariable models, whereas higher levels of citrate were associated with poor functional outcomes at discharge (OR 0.36, 95% CI 0.16-0.73) and at 3 months (OR 0.35, 95% CI 0.14-0.81). No associations were found with delayed cerebral ischemia. Levels of α-ketoglutarate and glutamine correlated with lower levels of interleukin-8, whereas fumarate was associated with lower levels of tumor necrosis factor alpha.
Aneurysmal subarachnoid hemorrhage results in a unique pattern of plasma metabolites, indicating a shift toward glycolysis. Higher levels of fumarate and lower levels of citrate were associated with better functional outcomes. These metabolites may represent targets to improve metabolism after aSAH.
动脉瘤性蛛网膜下腔出血(aSAH)会引发强烈的全身炎症反应。我们推测,aSAH后会发生早期全身糖酵解转变,从而产生独特的代谢特征并影响全身炎症。
对对照组患者和aSAH患者进行分析。aSAH患者的样本在动脉瘤破裂后24小时内采集。采用基于质谱的代谢组学方法评估参与三羧酸循环、糖酵解和磷酸戊糖途径的16种代谢物的相对丰度。主成分分析用于区分对照组患者和aSAH患者。绘制树形图以描述代谢物与细胞因子之间的相关性。建立预测功能结局的分析模型,并比较受试者工作曲线。
共纳入122例aSAH患者和38例对照患者。aSAH患者的糖酵解代谢物(3-磷酸甘油酸/2-磷酸甘油酸、乳酸)水平较高,但氧化代谢物(琥珀酸、苹果酸、富马酸和草酸盐)水平较低。临床严重程度较高(Hunt-Hess量表评分≥4)的患者3-磷酸甘油醛和柠檬酸水平较高,但α-酮戊二酸和谷氨酰胺水平较低。主成分分析很容易区分对照组患者和aSAH患者。相关性分析显示,对照组患者中存在aSAH患者未观察到的不同聚类。在多变量模型中,较高水平的富马酸与出院时良好的功能结局相关(优势比[OR]1.76,95%置信区间[CI]1.15-2.82),而较高水平的柠檬酸与出院时(OR 0.36,95%CI 0.16-0.73)和3个月时(OR 0.35,95%CI 0.14-0.81)不良的功能结局相关。未发现与迟发性脑缺血有关联。α-酮戊二酸和谷氨酰胺水平与白细胞介素-8水平较低相关,而富马酸与肿瘤坏死因子α水平较低相关。
动脉瘤性蛛网膜下腔出血导致血浆代谢物出现独特模式,表明向糖酵解转变。较高水平的富马酸和较低水平的柠檬酸与更好的功能结局相关。这些代谢物可能代表改善aSAH后代谢的靶点。